Clinical Trials Directory

Trials / Completed

CompletedNCT03292965

Monitoring of Postoperative Residual Neuromuscular Blockade in Laparoscopic Surgery

Monitoring of Postoperative Residual Neuromuscular Blockade in Laparoscopic Surgery: Comparison of Neostigmine and Sugammadex

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Seoul National University Bundang Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Compare the reversal effect of neostigmine and sugammadex using quantitative neuromuscular monitoring

Detailed description

At the end of surgery, decide the dosage of reversal referring to quantitative neuromuscular monitoring value (TOF). After the administration of reversal, the anesthesiologist who are going to manage the participant should not check the quantitative neuromuscular monitoring and determine the timing of extubation only with his (or her) judgement. After entering post-anaesthesia care unit (PACU) measure the TOF value and check the incidence of TOF ratio \> 0.9 between the neostigmine group and sugammadex group.

Conditions

Interventions

TypeNameDescription
DRUGNeostigmineReferring to the randomisation allocation program, participants allocated to group neostigmine, administrate neostigmine as reversal
DRUGSugammadexReferring to the randomisation allocation program, participants allocated to group sugammadex, administrate sugammadex as reversal

Timeline

Start date
2017-09-28
Primary completion
2017-11-29
Completion
2017-11-29
First posted
2017-09-26
Last updated
2018-10-09

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03292965. Inclusion in this directory is not an endorsement.